FUL as reported
H.B. Fuller Company reported $3.51B of revenue over the trailing twelve months, −0.57% on the year before. 11 reported series are charted on this page, each one as filed.
$3.51B
Revenue, trailing twelve months · to Q2 2026 · −0.57% against the twelve months before
- Net Income
- $186M
Net Income · +80% year on year · trailing twelve months to Q2 2026
- Free Cash Flow
- $141M
Free Cash Flow · +20% year on year · trailing twelve months to Q2 2026
- Op Margin
- 9.4%
Op Margin · trailing twelve months to Q3 2025
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $3.51B | −0.57% | Q2 2026 |
| Net Income | $186M | +80% | Q2 2026 |
| EPS | $3.37 | +82% | Q2 2026 |
| Gross Margin | 32% | n/a | Q2 2026 |
| Op Margin | 9.4% | n/a | Q3 2025 |
| Net Margin | 5.2% | n/a | Q2 2026 |
| ROE | 7.5% | n/a | Q2 2026 |
| ROA | 2.9% | n/a | Q2 2026 |
| ROIC | 6.9% | n/a | Q3 2025 |
| Free Cash Flow | $141M | +20% | Q2 2026 |
| P/E | 17.2 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
H.B. Fuller Company (FUL) - Revenue & ProfitRevenue & ProfitH.B. Fuller Company (FUL)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Specialty Chemicals
Ranks #25 of 36 by Smart Score